Literature DB >> 19827010

Tramadol dependence: a survey of spontaneously reported cases in Sweden.

Micaela Tjäderborn1, Anna K Jönsson, Johan Ahlner, Staffan Hägg.   

Abstract

BACKGROUND: Tramadol is a weak opioid analgesic, which is generally considered to be safe. However, conflicting data exist on the dependence potential of tramadol.
OBJECTIVE: The aim of this study was to investigate occurrence of tramadol dependence and associated risk factors using spontaneously reported adverse drug reactions.
METHODS: The Swedish database for spontaneously reported adverse drug reactions, Swedish Drug Information System (SweDIS), was searched for reports on tramadol dependence from 1 January 1995 until 31 December 2006. Selection was conducted based on the DSM-IV definition of dependence. Available information was scrutinised and registered and then presented descriptively.
RESULTS: A total of 104 reports of tramadol dependence were identified, of which 60 (58%) concerned women. The median age (range) was 45 (15-84) years. Information on a history of substance abuse was present in 31 patients (30%) and 41 patients (39%) had a documented past or current use of a drug of abuse. Prescribed doses of tramadol ranged between 50-800 mg/day, and ingested doses between 50-4000 mg/day. Time of onset ranged from some weeks up to 4 years. In 72 (69%) cases the reaction was classified as serious, mainly due to hospitalisations for detoxification or discontinuation of tramadol.
CONCLUSIONS: There is an occurrence of tramadol dependence in association with analgesic treatment within the recommended dose range. In susceptible patients a severe and serious dependence syndrome may develop. A history of abuse or use of a drug of abuse seems to be an important risk factor. Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19827010     DOI: 10.1002/pds.1838

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  8 in total

1.  PharmGKB summary: tramadol pathway.

Authors:  Li Gong; Ulrike M Stamer; Mladen V Tzvetkov; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-07       Impact factor: 2.089

Review 2.  [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].

Authors:  C Sommer; W Häuser; R Alten; F Petzke; M Späth; T Tölle; N Uçeyler; A Winkelmann; E Winter; K J Bär
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

3.  Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial.

Authors:  Michelle R Lofwall; Shanna Babalonis; Paul A Nuzzo; Anthony Siegel; Charles Campbell; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2013-06-04       Impact factor: 4.492

4.  High Rates of Tramadol Use among Treatment-Seeking Adolescents in Malmö, Sweden: A Study of Hair Analysis of Nonmedical Prescription Opioid Use.

Authors:  Martin O Olsson; Agneta Öjehagen; Louise Brådvik; Robert Kronstrand; Anders Håkansson
Journal:  J Addict       Date:  2017-12-24

5.  Opioid Prescribing After Surgery in the United States, Canada, and Sweden.

Authors:  Karim S Ladha; Mark D Neuman; Gabriella Broms; Jennifer Bethell; Brian T Bateman; Duminda N Wijeysundera; Max Bell; Linn Hallqvist; Tobias Svensson; Craig W Newcomb; Colleen M Brensinger; Lakisha J Gaskins; Hannah Wunsch
Journal:  JAMA Netw Open       Date:  2019-09-04

6.  Tramadol misuse in treatment-seeking adolescents and young adults with problematic substance use - Prediction of treatment retention.

Authors:  Eleonora Almér Herrnsdorf; Alexander Holmstedt; Anders Håkansson
Journal:  Addict Behav Rep       Date:  2022-07-11

7.  Tramadol dependence: a case series from India.

Authors:  Siddharth Sarkar; Naresh Nebhinani; Shubh M Singh; Surendra K Mattoo; Debasish Basu
Journal:  Indian J Psychol Med       Date:  2012-07

8.  Trends and patterns of analgesic prescribing in Malaysian public hospitals from 2010 to 2016: tramadol predominately used.

Authors:  Che Suraya Zin; Nor Ilyani Nazar; Norny Syafinaz Rahman; Nor Elina Alias; Wan Rohaidah Ahmad; Nurul Sahida Rani; Mary Suma Cardosa; Kim Swan Ng; Felicia Loh Ye
Journal:  J Pain Res       Date:  2018-09-20       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.